Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma | Zendy

Johan Mattsson Ulfstedt | Zendy; Per Venge | Zendy; Sofia Holmgren | Zendy; Gunilla Enblad | Zendy; Staffan Eriksson | Zendy; Daniel Molin | Zendy

Open Access

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

Author(s) -

Johan Mattsson Ulfstedt,

Per Venge,

Sofia Holmgren,

Gunilla Enblad,

Staffan Eriksson,

Daniel Molin

Publication year - 2021

Publication title -

upsala journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.808

H-Index - 41

eISSN - 2000-1967

pISSN - 0300-9734

DOI - 10.48101/ujms.v126.6119

Subject(s) - medicine , biomarker , lymphoma , antibody , thymidine kinase , hodgkin lymphoma , immunology , gastroenterology , virus , biology , biochemistry , herpes simplex virus

Thymidine kinase 1 (TK1) is an intracellular protein associated with DNA synthesis, expressed during the G1 phase and remained elevated through the M phase, with a potential as a biomarker for cell proliferation. In this study, we explore the possible use of TK1 in Hodgkin lymphoma (HL).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research